US 12060382
Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole
granted A61KA61K31/7056A61P
Quick answer
US patent 12060382 (Crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole) held by Takeda Pharmaceutical Company Limited expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/7056, A61P, A61P31/22